Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update.

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. World Allergy Organ J (2010) 2.01

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy (2016) 1.39

Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008. World Allergy Organ J (2012) 1.19

Sub-lingual immunotherapy: world allergy organization position paper 2009. World Allergy Organ J (2009) 1.03

The Prevalence of Serum Specific IgE to Superantigens in Asthma and Allergic Rhinitis Patients. Allergy Asthma Immunol Res (2014) 0.89

Allergy: a risk factor for suicide? Curr Treat Options Neurol (2008) 0.87

Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper. World Allergy Organ J (2010) 0.85

Sublingual immunotherapy in allergic rhinitis: efficacy, safety, adherence and guidelines. Clin Exp Otorhinolaryngol (2014) 0.80

Lack of bone metabolism side effects after 3 years of nasal topical steroids in children with allergic rhinitis. J Bone Miner Metab (2011) 0.79

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy (2016) 0.77

[Allergic rhinitis and its impact on asthma (ARIA update 2008). The Austrian perspective]. Wien Med Wochenschr (2009) 0.76

Therapeutic interventions in severe asthma. World Allergy Organ J (2016) 0.75

Comparative analysis of cluster versus conventional immunotherapy in patients with allergic rhinitis. Exp Ther Med (2017) 0.75

Credible knowledge: a pilot evaluation of a modified GRADE method using parent-implemented interventions for children with autism. BMC Health Serv Res (2011) 0.75

[GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers]. Wien Klin Wochenschr (2009) 0.75

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08

A methodological framework for assessing health indices. J Chronic Dis (1985) 9.76

Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis (1987) 9.25

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96

Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA (1994) 7.85

Academic medicine and the pharmaceutical industry: a cautionary tale. CMAJ (1994) 6.98

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07

A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81

Determining optimal therapy--randomized trials in individual patients. N Engl J Med (1986) 4.49

Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence-Based Medicine Working Group. JAMA (1995) 4.14

Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol (1999) 3.59

Validity and reliability of a questionnaire for measuring child oral-health-related quality of life. J Dent Res (2002) 3.59

Allergenic pollen and pollen allergy in Europe. Allergy (2007) 3.58

Computer searching of the medical literature. An evaluation of MEDLINE searching systems. Ann Intern Med (1985) 3.45

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy (1998) 3.20

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut (1999) 2.98

Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ (2000) 2.97

Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93

The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res (2008) 2.81

Effects of higher- versus lower-protein diets on health outcomes: a systematic review and meta-analysis. Eur J Clin Nutr (2012) 2.72

Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70

Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51

Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47

Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36

Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34

Phylogeny of nitrogenase sequences in Frankia and other nitrogen-fixing microorganisms. J Mol Evol (1989) 2.33

Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM (2010) 2.27

Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association. CMAJ (1995) 2.23

Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med (1998) 2.23

Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy (2007) 2.22

Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med (2008) 2.19

Inflammatory changes in conjunctival scrapings after allergen provocation in humans. J Allergy Clin Immunol (1988) 2.17

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. Am J Cardiol (1991) 2.13

Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy (2004) 2.13

Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13

Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med (2000) 2.08

Cost-effectiveness of inhaled beta-agonists v. oral salbutamol in asthma: a randomized double-blind cross-over study. Natl Med J India (1996) 2.05

Pro: Immunotherapy is clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med (2001) 2.04

Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab (1998) 1.97

Who benefits from immunotherapy? Allergy (1997) 1.97

Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting. J Thromb Haemost (2013) 1.97

Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy (2009) 1.97

New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med (2001) 1.95

Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91

Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90

Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med (1997) 1.87

Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (2000) 1.86

Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy (2008) 1.85

Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest (1998) 1.84

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy (2004) 1.84

Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82

Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med (2008) 1.82

Questionnaire for measuring oral health-related quality of life in eight- to ten-year-old children. Pediatr Dent (2005) 1.80

Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol (2001) 1.80

Using and understanding sedation scoring systems: a systematic review. Intensive Care Med (2000) 1.76

Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy (1991) 1.76

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy (2007) 1.75

Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med (2000) 1.75

Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med (1996) 1.74

GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72

Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72

Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy (2011) 1.71

A controlled trial of nurse practitioners in neonatal intensive care. Pediatrics (1996) 1.71

A survey of the burden of allergic rhinitis in Europe. Allergy (2007) 1.71

Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70

Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69

Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology (2000) 1.68

Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68

Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med (2012) 1.68

Measurement of the internal size of bronchi using high resolution computed tomography (HRCT) Eur Respir J (1994) 1.67

Predicting success in weaning from mechanical ventilation. Chest (2001) 1.66

A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. Allergy (2008) 1.66